Today

Agents

Chat

Arena

Discover

More

App

Amphastar Pharmaceuticals Q2 EPS USD 0.67 - AMPH News | Rallies

Amphastar Pharmaceuticals Q2 EPS USD 0.67

AMPH•2026-08-06

Q2 results beat revenue and adjusted EPS estimates

Aug. 6 (Reuters) - Amphastar Pharmaceuticals Q2 revenue was USD 183.903 million versus IBES estimate of USD 182.1 million.

Q2 adjusted net income was USD 40.759 million versus IBES estimate of USD 31.2 million
Q2 adjusted EPS was USD 0.91 versus IBES estimate of USD 0.62
Q2 net income was USD 30.348 million

Related News

US Antimony to webcast second-quarter results update

UAMY•2026-08-06

Valhi declares quarterly dividend of $0.08 a share

VHI•2026-08-06

I3 Verticals Q3 Revenue USD 53.067 Million Vs. IBES Estimate USD 55 Million

IIIV•2026-08-06

AMD deepens AI inference bet with Taalas deal as chip race heats up

AMD•2026-08-06

Canada's IAMGOLD Q2 adjusted EBITDA rises on higher gold prices

IAG•2026-08-06